Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Small cell lung cancer

Recruiting

Registered drugNo placebo

Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Topotecan

Contact Research Centre

Psoriasis

Recruiting

Registered drugNo placebo

Study on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

HER2 gene amplification

Recruiting

InvestigationalNo placebo

Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Zongertinib

Contact Research Centre

Ductal adenocarcinoma of pancreas

Recruiting

Registered drugNo placebo

Study of fluorouracil, irinotecan and oxaliplatin combination therapy for patients with metastatic pancreatic ductal adenocarcinoma who progressed after gemcitabine treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Uveal melanoma

Recruiting

Registered drugNo placebo

Title: Comparing tebentafusp treatment versus observation in patients with high-risk eye melanoma (uveal melanoma) after initial treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Tebentafusp

Contact Research Centre

Medulloblastoma

Recruiting

Registered drugNo placebo

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Carboplatin

Contact Research Centre

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Recruiting

Registered drugNo placebo

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Bortezomib

Contact Research Centre

Bronchopulmonary dysplasia

Recruiting

Investigational

Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies

Investigational

Belgium

Participants:0–17 years
Substances:Recombinant Human Surfactant Protein-D

Contact Research Centre

Haemolytic uraemic syndrome

Recruiting

Investigational

Study on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli

Investigational

Belgium

Participants:0–17 years
Substances:Equine Immunoglobulin F(Ab')2 Fragments Targeting Shiga Toxin

Contact Research Centre

Clostridium difficile infection

Recruiting

Investigational

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live

Contact Research Centre

Colon cancer metastatic

Recruiting

Registered drugNo placebo

Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Medulloblastoma

Recruiting

Registered drugNo placebo

Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 14

638 trials match your criteria

Small cell lung cancer

Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

Psoriasis

Study on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis

HER2 gene amplification

Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

Ductal adenocarcinoma of pancreas

Study of fluorouracil, irinotecan and oxaliplatin combination therapy for patients with metastatic pancreatic ductal adenocarcinoma who progressed after gemcitabine treatment

Uveal melanoma

Title: Comparing tebentafusp treatment versus observation in patients with high-risk eye melanoma (uveal melanoma) after initial treatment

Medulloblastoma

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Bronchopulmonary dysplasia

Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies

Haemolytic uraemic syndrome

Study on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli

Clostridium difficile infection

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Colon cancer metastatic

Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

Medulloblastoma

Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.